392 publications

Name Date Type Actions

Document d’enregistrement universel (URD) 2022 version XBRL

Document d'enregistrement universel 2022 incluant le rapport financier annuel

 		13/04/2023 Reference document

Availability of the 2022 universal registration document

On 13 April 2023, Vetoquinol filed its 2022 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format).

 		13/04/2023 Public releases

Buyback programs – March 2023

Monthly communication regarding buyback programs

 		05/04/2023 Monthly communication regarding buyback programs

Clone of Buyback programs – April 2023

Monthly communication regarding buyback programs

 		05/04/2023 Monthly communication regarding buyback programs

Buyback programs – May 2023

Monthly communication regarding buyback programs

 		05/04/2023 Monthly communication regarding buyback programs

Buyback programs – June 2023

Monthly communication regarding buyback programs

 		05/04/2023 Monthly communication regarding buyback programs

2022 ANNUAL RESULTS

Annual sales: €540m (up 3.6% as reported)
Essentials sales: €304m (up 4.5% as reported)
EBIT before depreciation of acquired assets: €99m (18.3% of sales)
Net income - Group share: €48m (8.9% of sales)
EBITDA: €118m (21.9% of sales)
Free cash-flow: €63m

 		23/03/2023 Public releases

Annual sales 2022

Total group Sales: €540 million (up 3.6% as reported)
Annual Sales of Essential products: €304 million (up 4.5% as reported)

 		18/01/2023 Public releases

First nine months 2022 sales: €405M

In line with year-end outlook

 		12/10/2022 Public releases

2022 HALF YEAR RESULTS Additional information on the Group’s strategy

Following the conference call organised on 15 September 2022 to present its half-year results, Vetoquinol would like to provide some additional information on the strategy implemented and its outlook.

 		23/09/2022 Public releases , Half Year Report